Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy: The SCARLET Randomized Clinical Trial.
Activated protein C reverses epigenetically sustained p66Shc expression in plaque-associated macrophages in diabetes.
